CLINICAL_TRIALS
trial_result
· 2025-09-05
Clinical Trial Update: [68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients [Phase 2]
Summary
A Phase 2 trial evaluating [68Ga]Ga-PentixaFor PET imaging in CNS lymphoma has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pentixapharm AG | Conditions: CNS Lymphoma | Phase 2 | Status: TERMINATED